Clinical Trials Browser

OTHER × talimogene laherparepvec × Gastrointestinal × Clear all

NCT03086642 2024-11-22

Study of Talimogene Laherparepvec (T-VEC) in Pancreatic Cancer

Phase 1 Completed

Gastrointestinal

Pancreatic Neoplasms